Prognostic potential of circulatory miR-19a-3p, miR-19b-3p, and miR-329-3p for future hypertension diagnosis.
Saved in:
| Title: | Prognostic potential of circulatory miR-19a-3p, miR-19b-3p, and miR-329-3p for future hypertension diagnosis. |
|---|---|
| Authors: | Kostiniuk D; Molecular Epidemiology Group., Blankenstein A; Department of Clinical Chemistry, Faculty of Medicine and Health Technology, Tampere University.; Fimlab Laboratories.; Finnish Cardiovascular Research Centre Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere., Rajić S; Molecular Epidemiology Group., Ciantar J; Molecular Epidemiology Group., Mononen N; Department of Clinical Chemistry, Faculty of Medicine and Health Technology, Tampere University.; Fimlab Laboratories.; Finnish Cardiovascular Research Centre Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere., Lyytikäinen LP; Department of Clinical Chemistry, Faculty of Medicine and Health Technology, Tampere University.; Fimlab Laboratories.; Finnish Cardiovascular Research Centre Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere., Seppälä I; Department of Clinical Chemistry, Faculty of Medicine and Health Technology, Tampere University.; Fimlab Laboratories.; Finnish Cardiovascular Research Centre Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere., Mishra PP; Department of Clinical Chemistry, Faculty of Medicine and Health Technology, Tampere University.; Fimlab Laboratories.; Finnish Cardiovascular Research Centre Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere., Juonala M; Division of Medicine Turku University Hospital and Department of Medicine, University of Turku, Turku, Finland., Waldenberger M; Research Unit Molecular Epidemiology, Institute of Epidemiology, Helmholtz Zentrum, German Research Centre for Environmental Health, Berlin, Germany., Elovainio M; Department of Psychology, Faculty of Medicine, University of Helsinki, Helsinki., Oksala N; Department of Clinical Chemistry, Faculty of Medicine and Health Technology, Tampere University.; Fimlab Laboratories.; Division of Medicine Turku University Hospital and Department of Medicine, University of Turku, Turku, Finland.; Centre for Vascular Surgery and Interventional Radiology, Wellbeing Services County of Pirkanmaa, Tampere University Hospital., Kähönen M; Department of Clinical Physiology, Tampere University Hospital, and Faculty of Medicine and Health Technology, Tampere University., Hutri N; Department of Pediatrics, University of Tampere and Tampere University Hospital, Tampere., Raitakari O; Centre for Population Health Research, University of Turku and Turku University Hospital.; Research Centre for Applied and Preventive Cardiovascular Medicine, University of Turku.; Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital.; InFLAMES Research Flagship, University of Turku, Turku, Finland., Kleber ME; Vth Department of Medicine (Nephrology, Hypertensiology, Endocrinology, Diabetology, Rheumatology), Medical Faculty of Mannheim, University of Heidelberg, Heidelberg.; SYNLAB MVZ Humangenetik Mannheim, Mannheim., März W; Vth Department of Medicine (Nephrology, Hypertensiology, Endocrinology, Diabetology, Rheumatology), Medical Faculty of Mannheim, University of Heidelberg, Heidelberg.; Synlab Academy, SYNLAB Holding Deutschland GmbH, Augsburg & Mannheim, Germany., Lehtimäki T; Department of Clinical Chemistry, Faculty of Medicine and Health Technology, Tampere University.; Fimlab Laboratories.; Finnish Cardiovascular Research Centre Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere., Marttila S; Molecular Epidemiology Group.; Tampere University Hospital, Wellbeing Services County of Pirkanmaa.; Gerontology Research Centre, Tampere University, Tampere, Finland., Raitoharju E; Molecular Epidemiology Group.; Fimlab Laboratories.; Finnish Cardiovascular Research Centre Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere. |
| Source: | Journal of hypertension [J Hypertens] 2026 May 01; Vol. 44 (5), pp. 811-822. Date of Electronic Publication: 2026 Mar 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wolters Kluwer Health, Inc Country of Publication: Netherlands NLM ID: 8306882 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5598 (Electronic) Linking ISSN: 02636352 NLM ISO Abbreviation: J Hypertens Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41818215 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Prognostic potential of circulatory miR-19a-3p, miR-19b-3p, and miR-329-3p for future hypertension diagnosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kostiniuk+D%22">Kostiniuk D</searchLink>; Molecular Epidemiology Group.<br /><searchLink fieldCode="AU" term="%22Blankenstein+A%22">Blankenstein A</searchLink>; Department of Clinical Chemistry, Faculty of Medicine and Health Technology, Tampere University.; Fimlab Laboratories.; Finnish Cardiovascular Research Centre Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere.<br /><searchLink fieldCode="AU" term="%22Rajić+S%22">Rajić S</searchLink>; Molecular Epidemiology Group.<br /><searchLink fieldCode="AU" term="%22Ciantar+J%22">Ciantar J</searchLink>; Molecular Epidemiology Group.<br /><searchLink fieldCode="AU" term="%22Mononen+N%22">Mononen N</searchLink>; Department of Clinical Chemistry, Faculty of Medicine and Health Technology, Tampere University.; Fimlab Laboratories.; Finnish Cardiovascular Research Centre Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere.<br /><searchLink fieldCode="AU" term="%22Lyytikäinen+LP%22">Lyytikäinen LP</searchLink>; Department of Clinical Chemistry, Faculty of Medicine and Health Technology, Tampere University.; Fimlab Laboratories.; Finnish Cardiovascular Research Centre Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere.<br /><searchLink fieldCode="AU" term="%22Seppälä+I%22">Seppälä I</searchLink>; Department of Clinical Chemistry, Faculty of Medicine and Health Technology, Tampere University.; Fimlab Laboratories.; Finnish Cardiovascular Research Centre Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere.<br /><searchLink fieldCode="AU" term="%22Mishra+PP%22">Mishra PP</searchLink>; Department of Clinical Chemistry, Faculty of Medicine and Health Technology, Tampere University.; Fimlab Laboratories.; Finnish Cardiovascular Research Centre Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere.<br /><searchLink fieldCode="AU" term="%22Juonala+M%22">Juonala M</searchLink>; Division of Medicine Turku University Hospital and Department of Medicine, University of Turku, Turku, Finland.<br /><searchLink fieldCode="AU" term="%22Waldenberger+M%22">Waldenberger M</searchLink>; Research Unit Molecular Epidemiology, Institute of Epidemiology, Helmholtz Zentrum, German Research Centre for Environmental Health, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Elovainio+M%22">Elovainio M</searchLink>; Department of Psychology, Faculty of Medicine, University of Helsinki, Helsinki.<br /><searchLink fieldCode="AU" term="%22Oksala+N%22">Oksala N</searchLink>; Department of Clinical Chemistry, Faculty of Medicine and Health Technology, Tampere University.; Fimlab Laboratories.; Division of Medicine Turku University Hospital and Department of Medicine, University of Turku, Turku, Finland.; Centre for Vascular Surgery and Interventional Radiology, Wellbeing Services County of Pirkanmaa, Tampere University Hospital.<br /><searchLink fieldCode="AU" term="%22Kähönen+M%22">Kähönen M</searchLink>; Department of Clinical Physiology, Tampere University Hospital, and Faculty of Medicine and Health Technology, Tampere University.<br /><searchLink fieldCode="AU" term="%22Hutri+N%22">Hutri N</searchLink>; Department of Pediatrics, University of Tampere and Tampere University Hospital, Tampere.<br /><searchLink fieldCode="AU" term="%22Raitakari+O%22">Raitakari O</searchLink>; Centre for Population Health Research, University of Turku and Turku University Hospital.; Research Centre for Applied and Preventive Cardiovascular Medicine, University of Turku.; Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital.; InFLAMES Research Flagship, University of Turku, Turku, Finland.<br /><searchLink fieldCode="AU" term="%22Kleber+ME%22">Kleber ME</searchLink>; Vth Department of Medicine (Nephrology, Hypertensiology, Endocrinology, Diabetology, Rheumatology), Medical Faculty of Mannheim, University of Heidelberg, Heidelberg.; SYNLAB MVZ Humangenetik Mannheim, Mannheim.<br /><searchLink fieldCode="AU" term="%22März+W%22">März W</searchLink>; Vth Department of Medicine (Nephrology, Hypertensiology, Endocrinology, Diabetology, Rheumatology), Medical Faculty of Mannheim, University of Heidelberg, Heidelberg.; Synlab Academy, SYNLAB Holding Deutschland GmbH, Augsburg & Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Lehtimäki+T%22">Lehtimäki T</searchLink>; Department of Clinical Chemistry, Faculty of Medicine and Health Technology, Tampere University.; Fimlab Laboratories.; Finnish Cardiovascular Research Centre Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere.<br /><searchLink fieldCode="AU" term="%22Marttila+S%22">Marttila S</searchLink>; Molecular Epidemiology Group.; Tampere University Hospital, Wellbeing Services County of Pirkanmaa.; Gerontology Research Centre, Tampere University, Tampere, Finland.<br /><searchLink fieldCode="AU" term="%22Raitoharju+E%22">Raitoharju E</searchLink>; Molecular Epidemiology Group.; Fimlab Laboratories.; Finnish Cardiovascular Research Centre Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228306882%22">Journal of hypertension</searchLink> [J Hypertens] 2026 May 01; Vol. 44 (5), pp. 811-822. <i>Date of Electronic Publication: </i>2026 Mar 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wolters+Kluwer+Health%2C+Inc%22">Wolters Kluwer Health, Inc </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8306882 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1473-5598 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202636352%22">02636352 </searchLink><i>NLM ISO Abbreviation: </i>J Hypertens <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41818215 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1097/HJH.0000000000004272 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 811 Titles: – TitleFull: Prognostic potential of circulatory miR-19a-3p, miR-19b-3p, and miR-329-3p for future hypertension diagnosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kostiniuk D – PersonEntity: Name: NameFull: Blankenstein A – PersonEntity: Name: NameFull: Rajić S – PersonEntity: Name: NameFull: Ciantar J – PersonEntity: Name: NameFull: Mononen N – PersonEntity: Name: NameFull: Lyytikäinen LP – PersonEntity: Name: NameFull: Seppälä I – PersonEntity: Name: NameFull: Mishra PP – PersonEntity: Name: NameFull: Juonala M – PersonEntity: Name: NameFull: Waldenberger M – PersonEntity: Name: NameFull: Elovainio M – PersonEntity: Name: NameFull: Oksala N – PersonEntity: Name: NameFull: Kähönen M – PersonEntity: Name: NameFull: Hutri N – PersonEntity: Name: NameFull: Raitakari O – PersonEntity: Name: NameFull: Kleber ME – PersonEntity: Name: NameFull: März W – PersonEntity: Name: NameFull: Lehtimäki T – PersonEntity: Name: NameFull: Marttila S – PersonEntity: Name: NameFull: Raitoharju E IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1473-5598 Numbering: – Type: volume Value: 44 – Type: issue Value: 5 Titles: – TitleFull: Journal of hypertension Type: main |
| ResultId | 1 |